ClinicalTrials.govpublic full text
Effects of Growth Hormone on the Nitric Oxide Pathway
cardiovascular disease, growth hormone, nitric oxide, nitrate, cyclic guanosine monophosphate, insulin-like growth factor-1, asymmetric dimethylarginine, blood pressure, endothelial progenitor cells, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 851081
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.